← Leaderboards
Timothy J Kinsella
Case Western Reserve University
$3,113,334
Attributed
$3,113,334
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2005–08$2M$1.5M$1M$500K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$5,138,102 · 5
By mechanism
U56$2,914,787 · 2
R01$2,077,934 · 2
P01$145,381 · 1
Top collaborators
No co-investigators on record.
Most similar at Case Western Reserve University
Same institution · by research overlap
- David A Boothman$11,670,216
- Nancy L Oleinick$4,281,905
- James Peter Basilion$13,402,848
- Duska M Separovic$2,115,239
- Zhenghong Lee$5,976,027
Others in their field
Top investigators on “Cytotoxicity”
- David Heimbrook · Leidos Biomedical Research, Inc.$60,494,681
- Philip J Disaia · University Of California Irvine$58,213,103
- Kent J. Weinhold · Duke University$45,381,151
- Brenda J. Weigel · University Of Minnesota$36,792,183
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$34,242,475
- Douglas F Nixon · J. David Gladstone Institutes$30,748,895
Research focus
CytotoxicityTissue /Cell CultureHigh Performance Liquid ChromatographyAthymic MouseGene MutationThymidineRadiation SensitivityDna RepairClinical Trial Phase IDrug Screening /EvaluationPharmacokineticsHuman Therapy EvaluationDna DamageIonizing RadiationRadiosensitizerColorectal NeoplasmsAnalogClinical ResearchIdoxuridineDrug MetabolismCell Growth RegulationDrug ResistanceCell CycleDrug Administration Rate /Duration
Grant awards (21)
Complex Systems & Control of MMR-Deficient Cells$468,042
U56 · FY2008 · CA · contact PI
Complex Systems & Control of MMR-Deficient Cells$468,042
U56 · FY2007 · CA · contact PI
Complex Systems & Control of MMR-Deficient Cells$180,000
U56 · FY2007 · CA · contact PI
Complex Systems & Control of MMR-Deficient Cells$302,189
U56 · FY2006 · CA · contact PI
Complex Systems & Control of MMR-Deficient Cells$9,304
U56 · FY2006 · CA · contact PI
Complex Systems &Control of MMR-Deficient Cells$455,385
U56 · FY2005 · CA
Complex Systems &Control of MMR-Deficient Cells$297,637
U56 · FY2005 · CA
Human Tumor Radiosensitization by IUdR and IPdR$254,363
R01 · FY2005 · CA
Complex Systems &Control of MMR-Deficient Cells$443,995
U56 · FY2004 · CA
Complex Systems &Control of MMR-Deficient Cells$290,193
U56 · FY2004 · CA
Human Tumor Radiosensitization by IUdR and IPdR$254,363
R01 · FY2004 · CA
Human Tumor Radiosensitization by IUdR and IPdR$254,363
R01 · FY2003 · CA
MISMATCH REPAIR DEFECTS AND HUMAN TUMOR RADIOSENSITIZATI$226,735
R01 · FY2003 · CA
Human Tumor Radiosensitization by IUdR and IPdR$251,038
R01 · FY2002 · CA
MISMATCH REPAIR DEFECTS AND HUMAN TUMOR RADIOSENSITIZATI$222,349
R01 · FY2002 · CA
Clinical phase I testing with phthalocyanine for skin malignancies$0
P01 · FY2002 · CA
MISMATCH REPAIR DEFECTS AND HUMAN TUMOR RADIOSENSITIZATI$218,089
R01 · FY2001 · CA
Clinical phase I testing with phthalocyanine for skin malignancies$0
P01 · FY2001 · CA
MISMATCH REPAIR DEFECTS AND HUMAN TUMOR RADIOSENSITIZATI$212,326
R01 · FY2000 · CA
RADIOSENSITIZATION BY HALOGENATED THYMIDINE ANALOGS$184,308
R01 · FY2000 · CA
Clinical phase I testing with phthalocyanine for skin malignancies$145,381
P01 · FY2000 · CA